Behfar Ehdaie MD, MPHAssistant Attending, Departments of Surgery (Urology Service), Epidemiology, and Biostatistics (Health Outcomes Group), Memorial Sloan-Kettering Cancer Center, New York, New York
Behfar Ehdaie, MD, MPH is an assistant attending in the Departments of Surgery (Urology Service) and Epidemiology and Biostatistics (Health Outcomes Group) at Memorial Sloan-Kettering Cancer Center. His clinical expertise includes using minimally invasive techniques—laparoscopic, robotic, and image-guided therapies—for the treatment of urologic malignancies, with an emphasis on prostate cancer.
Dr. Ehdaie’s research involves the development of promising new methods to diagnose, evaluate, and treat urologic malignancies. Through his involvement in Memorial Sloan Kettering Cancer Center’s comprehensive active surveillance program for patients with low-risk prostate cancer, he is conducting research that incorporates biomarkers and advanced imaging to detect cancer progression. In addition, Dr Ehdaie is exploring novel interventions to increase enrollment and adherence to active surveillance for patients with low risk tumors.
Dr. Ehdaie is a graduate of the Georgetown University School of Medicine. He completed his urology residency training in 2010 at the University of Virginia Health System, then a three-year fellowship in urologic oncology at MSKCC and a Master of Public Health degree at the Harvard School of Public Health.
Recent Contributions to PracticeUpdate:
- High-Intensity Focused Ultrasound for Unilateral Localized Prostate Cancer
- Prostate Cancer Screening: Balancing Benefits and Harms
- ERSPC: Screening and Prostate Cancer Mortality
- Establishing the Value of Multiparametric MRI in the Diagnosis of Prostate Cancer
- MRI-Fusion Biopsy for the Detection of Prostate Cancer